AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


Research in AACC’s Journal of Applied Laboratory Medicine reveals data of more than 160,000 adverse patient events occurring each year in the United States because of patient specimen identification errors involving clinical laboratories. Experts find different methods to implement quality checking for accurate results.
Keeping up with a continually changing drug testing environment challenges most clinicians. New drugs—sold illicitly—keep coming to market. Meanwhile, testing methods have variable performance, and drug testing recommendations evolve.

Ask the Expert


New technological developments typically have benefits and drawbacks. For laboratorians, implementing digital microscopy could result in greater efficiency, however it could also mean additional manual work and a change in computer software.

Bench Matters


Federal Insider


The Centers for Medicare and Medicaid Services has developed a new set of regulations for ordering and performing tests for COVID-19. While the agency eases requirements, labs will need to adhere to their state governors’ policies.

Industry Playbook


Regulatory Roundup


Special Supplement


With the rapid spread of the SARS-CoV-2 virus across the world, hospital laboratories had no choice but to respond as quickly as possible. In facing the pandemic, clinical laboratorians said a renewed sense of teamwork inside their labs, and outside with clinicians and manufacturers, continues to drive their spirited response…

The Sample